{
  "title": "M21-1, Part V, Subpart iii, Chapter 1, Section D - Osteomyelitis",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014418/M21-1-Part-V-Subpart-iii-Chapter-1-Section-D-Osteomyelitis",
  "content": "<-- Previous Section\nNext Section -->\nOverview\nIn This Section\nThis section contains the following topics:\nTopic\nTopic Name\n1\nOsteomyelitis\n2\nExamples of the Proper Rating Procedure for Osteomyelitis\n1\n.\nOsteomyelitis\nIntroduction\nThis topic contains information about osteomyelitis, including\nhistorical evaluations for osteomyelitis\nassigning historical evaluations for osteomyelitis\nreasons to discontinue a historical evaluation for osteomyelitis\nconstitutional symptoms of osteomyelitis\ncriteria for a 100-percent osteomyelitis evaluation\nactive osteomyelitis associated with noncompensable amputation\n, and\napplication of the amputation rule to evaluations for osteomyelitis\n.\nChange Date\nNovember 8, 2021\nV.iii.1.D.1.a\n.\nHistorical Evaluation for Osteomyelitis\nBoth the 10-percent evaluation and that part of the 20-percent evaluation that is based on “other evidence of active infection within the last five years” are\nhistorical evaluations, and\nbased on recurrent episodes of osteomyelitis.\nNote\n:  The 20-percent historical evaluation based on evidence of active infection within the past five years\nmust\nbe distinguished from the 20-percent evaluation authorized when there is a discharging sinus.\nV.iii.1.D.1.b\n.\nAssigning Historical Evaluations for Osteomyelitis\nAn initial episode of active osteomyelitis is\nnot\na basis for either of the historical evaluations.\nAssign the historical evaluation as follows:\nWhen the first\nrecurrent\nepisode of osteomyelitis is shown\nassign a 20-percent historical evaluation, and\nextend the evaluation for five years from the date of examination showing the osteomyelitis to be inactive.\nAssign a closed evaluation at the expiration of the five-year extension.\nAssign the 10-percent historical evaluation only if there have been two or more recurrences of active osteomyelitis following the initial infection.\nV.iii.1.D.1.c\n.\nReasons to Discontinue a Historical  Evaluation for Osteomyelitis\nDo\nnot\ndiscontinue the historical evaluation, even if treatment includes saucerization, sequestrectomy, or guttering, because the osteomyelitis is not considered cured.\nException\n:  If there has been removal or radical resection of the affected bone\nconsider osteomyelitis cured, and\ndiscontinue the historical evaluation.\nV.iii.1.D.1.d\n.\nConstitutional Symptoms of Osteomyelitis\nConstitutional symptoms are a prerequisite to the assignment of a 60-percent evaluation under\n38 CFR 4.71a, diagnostic code (DC) 5000\n.\nUnder the 100 percent criteria, as discussed in\nM21-1, Part V, Subpart iii, 1.D.1.e\n, the presence of continuous constitutional symptoms is one facet for consideration in the assignment of the 100-percent evaluation.\nWhen the evaluation of osteomyelitis is based on constitutional symptoms, it is not subject to the amputation rule.\nReferences\n:  For more information on the\namputation rule, see\n38 CFR 4.68\n, and\nhistorical policy interpretation of the requirement for constitutional systems for 100-percent evaluations, see the attachment\nHistorical_M21-1V_iii_1_SecD_9-15-21\n.\nV.iii.1.D.1.e\n.\nCriteria for a 100-Percent Osteomyelitis Evaluation\nThe plain language of\n38 CFR 4.71a, DC 5000\ndoes not require an active infection to establish a 100-percent evaluation for osteomyelitis.  Demonstration of chronic, acute, or subacute osteomyelitis with any of the following warrants entitlement to a 100-percent evaluation:\ninvolvement\nof the pelvis\nof the vertebrae, or\nextending into the major joints\nwith multiple locations, or\nwith a long history of intractability and debility, anemia, amyloid liver changes, or other continuous constitutional symptoms.\nNote\n:  The guidance in this block represents a change in the Department of Veterans Affairs policy related to the evaluation of osteomyelitis at the 100-percent rate as effected by the holding of the Court of Appeals for Veterans Claims in\nHuerta v. McDonough\n, 34 Vet.App. 76 (2021), decided on April 27, 2021.\nReference\n:  For more information on assigning effective dates based on judicial precedents, see\nM21-1, Part V, Subpart ii, 4.A.6.n\n.\nV.iii.1.D.1.f\n.\nActive Osteomyelitis Associated With Noncompensable Amputation\nWhen the evaluation for amputation of an extremity or body part affected by osteomyelitis would be zero percent, assign a 10-percent evaluation if there is active osteomyelitis.\nV.iii.1.D.1.g\n.\nApplication of the Amputation Rule to Evaluations for Osteomyelitis\nUse the following table to determine how the amputation rule affects evaluations assigned for osteomyelitis.\nIf the osteomyelitis evaluation is ...\nThen the amputation rule ...\n10 percent based on active osteomyelitis of a body part where the amputation evaluation would normally be zero percent\ndoes not apply.\n10 percent based on active osteomyelitis of a body part where the amputation evaluation would normally be zero percent, or\n30 percent or less under\n38 CFR 4.71a, DC 5000\n,\nand\nthe 10-percent evaluation is combined with evaluations for\nankylosis\nlimited motion\nnonunion or malunion\nshortening, or\nother musculoskeletal impairment\napplies to the combined evaluation.\nNote\n:  For osteomyelitis of the vertebrae or pelvis, extending into major joints, or affecting multiple locations, refer to the final row of this table.\n60 percent based on constitutional symptoms of osteomyelitis, per\n38 CFR 4.71a, DC 5000\ndoes not apply since the 60-percent evaluation is based on constitutional symptoms.\n100 percent, as described in\nM21-1, Part V, Subpart iii, 1.D.1.e\n(including osteomyelitis of the pelvis or extending into the major joints)\ndoes not apply.\nReference\n:  For more information on the amputation rule, see\n38 CFR 4.68\n, and\nM21-1, Part V, Subpart iii, 1.F.1.e\n.\n2\n.\nExamples of the Proper Rating Procedure for Osteomyelitis\nIntroduction\nThis exhibit contains eight examples of the proper procedure for rating osteomyelitis, including an example of evaluating\nosteomyelitis based on a history of a single active initial episode\nan active initial episode of osteomyelitis\nosteomyelitis\nfollowing review exam for initial active episode\nwith current discharging sinus\n, and\nwith a historical evaluation following a single recurrence with scheduled reduction due to inactivity\na recurrence of osteomyelitis\nosteomyelitis following\nsecond recurrence\n, and\ncurative resection of affected bone\n, and\nchronic osteomyelitis\n.\nChange Date\nNovember 8, 2021\nV.iii.1.D.2.a\n.\nExample of Evaluating Osteomyelitis Based on a History of a Single Active Initial Episode\nSituation\n:  The Veteran was diagnosed with osteomyelitis in service with discharging sinus.  At separation from service the osteomyelitis was inactive with no involucrum or sequestrum.  There is no evidence of recurrence.\nResult\n:  As there has been no recurrence of active osteomyelitis following the initial episode in service, the historical evaluation of 20 percent is not for application.  The requirements for a 20-percent evaluation based on activity are not met either.\nCoded Conclusion\n:\n1. SC (PTE INC)\n5000\nOsteomyelitis, right tibia\n0% from 12-2-93\nNote\n:  For the scenarios discussed in\nM21-1, Part V, Subpart iii, 1.D.2.a\n-\nh\n, when the scenario involves dates, review the scenarios as if the actions are being taken at or near the time of the evidence presented in each scenario.  In other words, for the purposes of reviewing these scenarios only, do not apply protection of evaluation under\n38 CFR 3.951(b)\n.\nV.iii.1.D.2.b\n.\nExample of Evaluating an Active Initial Episode of Osteomyelitis\nSituation\n:  Same facts as example shown in\nM21-1, Part V, Subpart iii, 1.D.2.a\n, but the Veteran had a discharging sinus at the time of separation from service.\nResult\n:  The Veteran meets the criteria for a 20-percent evaluation based on a discharging sinus.  Schedule a future examination to ascertain the date of inactivity.\nCoded Conclusion\n:\n1. SC (PTE INC)\n5000\nOsteomyelitis, right tibia, active\n20% from 12-2-93\nReference\n:  For more information on the assignment of a 20-percent evaluation when there is a discharging sinus, see\nM21-1, Part V, Subpart iii, 1.D.1.a\nand\nb\n.\nV.iii.1.D.2.c\n.\nExample of Evaluating Osteomyelitis Following Review Exam for Initial Active Episode\nSituation\n:  Same facts as example shown in\nM21-1, Part V, Subpart iii, 1.D.2.b\n.  Subsequent review examination reveals the sinus tract was healed and there is no other evidence of active infection.\nResult\n:  Since the Veteran has not had a recurrent episode of osteomyelitis since service, a historical rating of 20 percent is not for application.  Take rating action under\n38 CFR 3.105(e)\n.\nCoded Conclusion\n:\n1. SC (PTE INC)\n5000\nOsteomyelitis, right tibia, inactive\n20% from 12-2-93\n0% from 3-1-95\nV.iii.1.D.2.d\n.\nExample of Evaluating Osteomyelitis With Current Discharging Sinus\nSituation\n:  Same facts as example shown in\nM21-1, Part V, Subpart iii, 1.D.2.b\n.  The Veteran is hospitalized July 21, 1996, with active osteomyelitis of the right tibia shown with discharging sinus.  There is no involucrum, sequestrum, or constitutional symptom.  Upon release from the hospital the discharging sinus is still present.\nResult\n:  Assign the 20-percent evaluation based on evidence showing draining sinus from the proper effective date.  Schedule a future examination to ascertain date of inactivity.\nCoded Conclusion\n:\n1. SC (PTE INC)\n5000\nOsteomyelitis, right tibia, active\n0% from 3-1-95\n20% from 7-21-96\nReference\n:  For more information on the assignment of a 20-percent evaluation when there is a discharging sinus, see\nM21-1, Part V, Subpart iii, 1.D.1.a\nand\nb\n.\nV.iii.1.D.2.e\n.\nExample of Evaluating Osteomyelitis With a Historical Evaluation Following a Single Recurrence With Scheduled Reduction Due to Inactivity\nSituation\n:  Same facts as example shown in\nM21-1, Part V, Subpart iii, 1.D.2.d\n.  A routine future examination was conducted on July 8, 1997, showing the osteomyelitis to be inactive.  There was no discharging sinus, no involucrum, sequestrum, or constitutional symptom.  The most recent episode of active osteomyelitis (July 21, 1996) constitutes the first “recurrent” episode of active osteomyelitis.\nResult\n:  Continue the previously assigned 20-percent evaluation, which was awarded on the basis of discharging sinus as a historical evaluation for five years from the examination showing inactivity.  Assign a future ending date for the historical 20-percent evaluation 5 years from the date evidence shows inactivity.\nCoded Conclusion\n:\n1. SC (PTE INC)\n5000\nOsteomyelitis, right tibia, inactive\n20% from 7-21-96\n0% from 7-8-02\nReferences\n:  For more information on\nassigning historical evaluations for osteomyelitis, see\nM21-1, Part V, Subpart iii, 1.D.1.a\nand\nb\n, and\n38 CFR 4.71a, DC 5000, Note 2\n, and\ndetermining whether recurrent episodes of osteomyelitis have occurred, see\nM21-1, Part V, Subpart iii, 1.D.1.b\n.\nV.iii.1.D.2.f\n.\nExample of Evaluating a Recurrence of Osteomyelitis\nSituation\n:  Same facts as example shown in\nM21-1, Part V, Subpart iii, 1.D.2.e\n.  In October 1999, the Veteran was again found to have active osteomyelitis with a discharging sinus, without involucrum, sequestrum, or constitutional symptoms.\nResult\n:  Continue the 20-percent evaluation.  Reevaluation is necessary to remove the future reduction to zero percent and to schedule a future examination to establish the date of inactivity.\nCoded Conclusion\n:\n1. SC (PTE INC)\n5000\nOsteomyelitis, right tibia, active\n20% from 7-21-96\nV.iii.1.D.2.g\n.\nExample of Evaluating Osteomyelitis Following Second Recurrence\nSituation\n:  Same facts as example shown in\nM21-1, Part V, Subpart iii, 1.D.2.f\n.  A review examination was conducted on April 8, 2000.  The examination showed the discharging sinus was inactive, and there was no other evidence of active osteomyelitis.  The most recent episode of osteomyelitis (October 1999) constitutes the second \"recurrent\" episode of active osteomyelitis.\nResult\n:  The historical evaluations of 20 and 10 percent both apply.  Continue the 20-percent evaluation based on the historical criteria requiring activity within the past 5 years.  Assign a future ending date for the 20-percent evaluation 5 years from the date of last activity via assigning the lower 10-percent evaluation based on the historical criteria requiring inactive osteomyelitis following repeated episodes without active infection in the past 5 years.\nCoded Conclusion\n:\n1. SC (PTE INC)\n5000\nOsteomyelitis, right tibia, inactive\n20% from 7-21-96\n10% from 4-8-05\nReferences\n:  For more information on\nassigning historical evaluations for osteomyelitis, see\nM21-1, Part V, Subpart iii, 1.D.1.a\nand\nb\n, and\n38 CFR 4.71a, DC 5000, Note 2\n, and\ndetermining whether recurrent episodes of osteomyelitis have occurred, see\nM21-1, Part V, Subpart iii, 1.D.1.b\n.\nV.iii.1.D.2.h\n.\nExample of Evaluating Osteomyelitis Following Curative Resection of Affected Bone\nSituation\n:  Same facts as example shown in\nM21-1, Part V, Subpart iii, 1.D.2.g\n.  The Veteran was hospitalized June 10, 2002, with a recurrent episode of active osteomyelitis.  A radical resection of the right tibia was performed and at hospital discharge (June 21, 2002), the osteomyelitis was shown to be cured.\nResult\n:  Assign a temporary total evaluation of 100 percent under\n38 CFR 4.30\nwith a 1-month period of convalescence.  Following application of\n38 CFR 3.105(e)\n, reduce the evaluation for osteomyelitis to zero percent as an evaluation for osteomyelitis will not be applied following cure by removal or radical resection of the affected bone.\nCoded Conclusion\n:\n1. SC (PTE INC)\n5000\nOsteomyelitis, right tibia, P.O.\n20% from 7-21-96\n100% from 6-10-02 (Par. 30)\n20% from 8-1-02\n0% from 10-1-02\nV.iii.1.D.2.i\n.\nExample of Evaluating Chronic Osteomyelitis\nSituation\n:  During active service, a Veteran sustained an injury requiring a bone graft from the pelvis.  A year later, the Veteran was found to have osteomyelitis at the site of the bone graft.  Symptoms were treated with a course of antibiotics.  The Veteran’s symptoms recurred four years later.  Surgical intervention was utilized to treat soft tissue residuals of the osteomyelitis infection.  A chronic sinus tract was found during the surgery.  Two years later, the bone graft site again became infected and was treated with antibiotics, incision, and drainage.  An x-ray confirmed active osteomyelitis at that time.  A follow-up record one year later confirmed no further drainage or symptoms.  Further treatment and follow-up was recommended as physicians suspected that the disease process continued.  However, records thereafter reveal no further treatment.\nThe Veteran submitted a claim for service connection twenty years after the treatment of the last active episode.  No current active infection or symptomatology is shown.\nResult\n:  Assign a 100-percent evaluation based on the history of chronic osteomyelitis extending into the pelvis.\n<-- Previous Section\nNext Section -->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><div class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014413\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section C - Arthritis\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014413/M21-1-Part-V-Subpart-iii-Chapter-1-Section-C-Arthritis\">&lt;-- Previous Section</a>  <a articleid=\"554400000014422\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section E - Muscle Injuries\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014422/M21-1-Part-V-Subpart-iii-Chapter-1-Section-E-Muscle-Injuries\">Next Section --&gt;</a></span></span></div><h2 class=\"ng-scope\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">Overview</span></span></a></h2><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">In This Section</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This section contains the following topics: </span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 has the topic number and column 2 has the topic title.\" width=\"485\"><thead><tr><th scope=\"col\" style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Topic</span></span></div></th><th scope=\"col\" style=\"width: 399px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Topic Name</span></span></div></th></tr></thead><tbody><tr><td style=\"height: 16px; width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">1</span></span></div></td><td style=\"height: 16px; width: 399px; padding: 1px;\"><div><a href=\"#1\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Osteomyelitis</span></span></a></div></td></tr><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">2</span></span></div></td><td style=\"width: 399px; padding: 1px;\"><div><a href=\"#2\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Examples of the Proper Rating Procedure for Osteomyelitis</span></span></a></div></td></tr></tbody></table><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/><br/><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div class=\"ng-scope\"><h2><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">1<a id=\"1\" name=\"1\">.</a>  Osteomyelitis</span></span></h2><p><br/> </p><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This topic contains information about osteomyelitis, including</span></span></div><ul><li><div><a href=\"#1a\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">historical evaluations for osteomyelitis</span></span></a></div></li><li><div><a href=\"#1b\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">assigning historical evaluations for osteomyelitis</span></span></a></div></li><li><div><a href=\"#1c\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">reasons to discontinue a historical evaluation for osteomyelitis</span></span></a></div></li><li><div><a href=\"#1d\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">constitutional symptoms of osteomyelitis</span></span></a></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#1e\" target=\"_self\">criteria for a 100-percent osteomyelitis evaluation</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#1f\" target=\"_self\">active osteomyelitis associated with noncompensable amputation</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#1g\" target=\"_self\">application of the amputation rule to evaluations for osteomyelitis</a>.</span></span></div></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">November 8, 2021</span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.1.D.1.a<a id=\"1a\" name=\"1a\">.</a>  Historical Evaluation for Osteomyelitis</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Both the 10-percent evaluation and that part of the 20-percent evaluation that is based on “other evidence of active infection within the last five years” are</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">historical evaluations, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">based on recurrent episodes of osteomyelitis.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  The 20-percent historical evaluation based on evidence of active infection within the past five years <em>must</em> be distinguished from the 20-percent evaluation authorized when there is a discharging sinus.</span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.1.D.1.b<a id=\"1b\" name=\"1b\">.</a>  Assigning Historical Evaluations for Osteomyelitis</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">An initial episode of active osteomyelitis is <em>not</em> a basis for either of the historical evaluations.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Assign the historical evaluation as follows:</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">When the first <em>recurrent</em> episode of osteomyelitis is shown</span></span><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">assign a 20-percent historical evaluation, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">extend the evaluation for five years from the date of examination showing the osteomyelitis to be inactive.</span></span></li></ul></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Assign a closed evaluation at the expiration of the five-year extension.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Assign the 10-percent historical evaluation only if there have been two or more recurrences of active osteomyelitis following the initial infection.</span></span></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\">V.iii.1.D.1.c<a id=\"1c\" name=\"1c\">.</a>  Reasons to Discontinue a Historical  Evaluation for Osteomyelitis</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Do<em> not</em> discontinue the historical evaluation, even if treatment includes saucerization, sequestrectomy, or guttering, because the osteomyelitis is not considered cured.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Exception</em></strong>:  If there has been removal or radical resection of the affected bone</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">consider osteomyelitis cured, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">discontinue the historical evaluation.</span></span></div></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: Arial, Helvetica, sans-serif\">V.iii.1.D.1.d<a id=\"1d\" name=\"1d\">.</a>  Constitutional Symptoms of Osteomyelitis</span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Constitutional symptoms are a prerequisite to the assignment of a 60-percent evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, diagnostic code (DC) 5000</a>.</span></span></div><div><div></div><div class=\"MsoBlockText\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">Under the 100 percent criteria, as discussed in <a href=\"#1e\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.1.e</a>, the presence of continuous constitutional symptoms is one facet for consideration in the assignment of the 100-percent evaluation. </span></span></div><div class=\"MsoBlockText\"></div><div class=\"MsoBlockText\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">When the evaluation of osteomyelitis is based on constitutional symptoms, it is not subject to the amputation rule.</span></span></div><div class=\"MsoBlockText\"></div><div class=\"MsoBlockText\"><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>References</i></b>:  For more information on the</span></span></div><ul><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">amputation rule, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=se38.1.4_168&amp;rgn=div8\" target=\"_blank\">38 CFR 4.68</a>, and</span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">historical policy interpretation of the requirement for constitutional systems for 100-percent evaluations, see the attachment <i>Historical_M21-1V_iii_1_SecD_9-15-21</i>.</span></span></div></li></ul></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-family: Arial, Helvetica, sans-serif\">V.iii.1.D.1.e<a id=\"1e\" name=\"1e\">.</a>  Criteria for a 100-Percent Osteomyelitis Evaluation</span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The plain language of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5000</a> does not require an active infection to establish a 100-percent evaluation for osteomyelitis.  Demonstration of chronic, acute, or subacute osteomyelitis with any of the following warrants entitlement to a 100-percent evaluation:</span></span></div><ul><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">involvement</span></span></div><ul><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">of the pelvis</span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">of the vertebrae, or</span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">extending into the major joints</span></span></div></li></ul></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">with multiple locations, or</span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">with a long history of intractability and debility, anemia, amyloid liver changes, or other continuous constitutional symptoms.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Note</i></b>:  The guidance in this block represents a change in the Department of Veterans Affairs policy related to the evaluation of osteomyelitis at the 100-percent rate as effected by the holding of the Court of Appeals for Veterans Claims in <a articleid=\"554400000186507\" articlename=\"Huerta v. McDonough, April 27, 2021, 34 Vet. App. 76\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000186507/Huerta-v-McDonough-April-27-2021-34-Vet-App-76\"><i>Huerta v. McDonough</i></a>, 34 Vet.App. 76 (2021), decided on April 27, 2021.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i><span style=\"color: black\">Reference</span></i></b><span style=\"color: black\">:  For more information on assigning effective dates based on judicial precedents, see <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">M21-1, Part V, Subpart ii, 4.A.6.n</a>.</span></span></span></div></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.D.1.f<a id=\"1f\" name=\"1f\">.</a>  Active Osteomyelitis Associated With Noncompensable Amputation</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">When the evaluation for amputation of an extremity or body part affected by osteomyelitis would be zero percent, assign a 10-percent evaluation if there is active osteomyelitis.</span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.D.1.g<a id=\"1g\" name=\"1g\">.</a>  Application of the Amputation Rule to Evaluations for Osteomyelitis</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Use the following table to determine how the amputation rule affects evaluations assigned for osteomyelitis.</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a evaluation-amputation rule table.  Column 1 contains the osteomyelitis evaluation and column 2 contains the amputation rule.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 258px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>If the osteomyelitis evaluation is ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 252px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Then the amputation rule ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">10 percent based on active osteomyelitis of a body part where the amputation evaluation would normally be zero percent</span></span></div></td><td style=\"width: 252px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">does not apply.</span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">10 percent based on active osteomyelitis of a body part where the amputation evaluation would normally be zero percent, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">30 percent or less under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=b311fb502bb95064c304abc01770f498&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5000</a>, <em>and</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the 10-percent evaluation is combined with evaluations for</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">ankylosis</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">limited motion</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">nonunion or malunion</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">shortening, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">other musculoskeletal impairment</span></span></div></li></ul></li></ul></td><td style=\"width: 252px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">applies to the combined evaluation.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em><strong>Note</strong></em>:  For osteomyelitis of the vertebrae or pelvis, extending into major joints, or affecting multiple locations, refer to the final row of this table. </span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">60 percent based on constitutional symptoms of osteomyelitis, per <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=b311fb502bb95064c304abc01770f498&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5000</a></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">does not apply since the 60-percent evaluation is based on constitutional symptoms.</span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">100 percent, as described in <a href=\"#1e\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.1.e</a> (including osteomyelitis of the pelvis or extending into the major joints)</span></span></div></td><td style=\"width: 252px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">does not apply.</span></span></div></td></tr></tbody></table><div style=\"margin-left: 7.9pt\"></div><div style=\"margin-left: 7.9pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on the amputation rule, see</span></span></div><ul><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=20e6c35d263fcb18012ae2dfcf3e5d46&amp;node=se38.1.4_168&amp;rgn=div8\" target=\"_blank\">38 CFR 4.68</a>, and</span></span></div></li><li style=\"margin-left: 7.9pt\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014425\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section F - Other Musculoskeletal Considerations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014425/M21-1-Part-V-Subpart-iii-Chapter-1-Section-F-Other-Musculoskeletal-Considerations\">M21-1, Part V, Subpart iii, 1.F.1.e</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><p> <br/> </p><h2><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">2<a id=\"2\" name=\"2\">.</a>  Examples of the Proper Rating Procedure for Osteomyelitis</span></span></h2><p><br/><br/> </p><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This exhibit contains eight examples of the proper procedure for rating osteomyelitis, including an example of evaluating</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2a\" target=\"_self\">osteomyelitis based on a history of a single active initial episode</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2b\" target=\"_self\">an active initial episode of osteomyelitis</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">osteomyelitis</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2c\" target=\"_self\">following review exam for initial active episode</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2d\" target=\"_self\">with current discharging sinus</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2e\" target=\"_self\">with a historical evaluation following a single recurrence with scheduled reduction due to inactivity</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2f\" target=\"_self\">a recurrence of osteomyelitis</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">osteomyelitis following </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2g\" target=\"_self\">second recurrence</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2h\" target=\"_self\">curative resection of affected bone</a>, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2i\" target=\"_self\">chronic osteomyelitis</a>.</span></span></div></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">November 8, 2021</span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.D.2.a<a id=\"2a\" name=\"2a\">.</a>  Example of Evaluating Osteomyelitis Based on a History of a Single Active Initial Episode</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Situation</em></strong>:  The Veteran was diagnosed with osteomyelitis in service with discharging sinus.  At separation from service the osteomyelitis was inactive with no involucrum or sequestrum.  There is no evidence of recurrence.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Result</em></strong>:  As there has been no recurrence of active osteomyelitis following the initial episode in service, the historical evaluation of 20 percent is not for application.  The requirements for a 20-percent evaluation based on activity are not met either.</span></span></div><div></div><div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"This is the coded conclusion for this example.\"><thead><tr><th scope=\"col\" style=\"height: 18px; width: 149px; padding: 1px;\"><div align=\"left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><strong>Coded Conclusion</strong></em>:</span></span></div></th><th scope=\"col\" style=\"height: 18px; width: 354px; padding: 1px;\"></th></tr></thead><tbody><tr><td style=\"height: 18px; width: 149px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">1. SC (PTE INC)</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">5000</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Osteomyelitis, right tibia</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">0% from 12-2-93</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 1px;\"></td></tr></tbody></table></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  For the scenarios discussed in <a href=\"#2a\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.2.a</a>-<a href=\"#2h\" target=\"_self\">h</a>, when the scenario involves dates, review the scenarios as if the actions are being taken at or near the time of the evidence presented in each scenario.  In other words, for the purposes of reviewing these scenarios only, do not apply protection of evaluation under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=92932f5845e33fcc776900678bb1dec3&amp;mc=true&amp;node=se38.1.3_1951&amp;rgn=div8\" target=\"_blank\">38 CFR 3.951(b)</a>.</span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.D.2.b<a id=\"2b\" name=\"2b\">.</a>  Example of Evaluating an Active Initial Episode of Osteomyelitis</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  Same facts as example shown in <a href=\"#2a\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.2.a</a>, but the Veteran had a discharging sinus at the time of separation from service.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  The Veteran meets the criteria for a 20-percent evaluation based on a discharging sinus.  Schedule a future examination to ascertain the date of inactivity.</span></span></div><div></div><div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"This is the coded conclusion for this example.\"><thead><tr><th scope=\"col\" style=\"height: 18px; width: 149px; padding: 1px;\"><div align=\"left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em><strong>Coded Conclusion</strong></em>:</span></span></div></th><th scope=\"col\" style=\"height: 18px; width: 354px; padding: 1px;\"></th></tr></thead><tbody><tr><td style=\"height: 18px; width: 149px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">1. SC (PTE INC)</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">5000</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Osteomyelitis, right tibia, active</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">20% from 12-2-93</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 1px;\"></td></tr></tbody></table></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em><strong>Reference</strong></em>:  For more information on the assignment of a 20-percent evaluation when there is a discharging sinus, see <a href=\"#1a\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.1.a</a> and <a href=\"#1b\" target=\"_self\">b</a>.</span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.D.2.c<a id=\"2c\" name=\"2c\">.</a>  Example of Evaluating Osteomyelitis Following Review Exam for Initial Active Episode</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  Same facts as example shown in <a href=\"#2b\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.2.b</a>.  Subsequent review examination reveals the sinus tract was healed and there is no other evidence of active infection. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Since the Veteran has not had a recurrent episode of osteomyelitis since service, a historical rating of 20 percent is not for application.  Take rating action under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=a18de443791ac76fbe390708ba1a3421&amp;mc=true&amp;node=se38.1.3_1105&amp;rgn=div8\" target=\"_blank\">38 CFR 3.105(e)</a>.</span></span></div><div></div><div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"This is the coded conclusion for this example.\"><thead><tr><th scope=\"col\" style=\"height: 18px; width: 149px; padding: 1px;\"><div align=\"left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em><strong>Coded Conclusion</strong></em>:</span></span></div></th><th scope=\"col\" style=\"height: 18px; width: 354px; padding: 1px;\"></th></tr></thead><tbody><tr><td style=\"height: 18px; width: 149px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">1. SC (PTE INC)</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">5000</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Osteomyelitis, right tibia, inactive</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">20% from 12-2-93</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">0% from 3-1-95</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 1px;\"></td></tr></tbody></table></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">  </span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.D.2.d<a id=\"2d\" name=\"2d\">.</a>  Example of Evaluating Osteomyelitis With Current Discharging Sinus</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  Same facts as example shown in <a href=\"#2b\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.2.b</a>.  The Veteran is hospitalized July 21, 1996, with active osteomyelitis of the right tibia shown with discharging sinus.  There is no involucrum, sequestrum, or constitutional symptom.  Upon release from the hospital the discharging sinus is still present. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Assign the 20-percent evaluation based on evidence showing draining sinus from the proper effective date.  Schedule a future examination to ascertain date of inactivity.</span></span></div><div></div><div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\" summary=\"This is the coded conclusion for this example.\"><thead><tr><th scope=\"col\" style=\"height: 18px; width: 149px; padding: 0px;\"><div align=\"left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><strong>Coded Conclusion</strong></em>:</span></span></div></th><th scope=\"col\" style=\"height: 18px; width: 354px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></th></tr></thead><tbody><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">1. SC (PTE INC)</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">5000</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Osteomyelitis, right tibia, active</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">0% from 3-1-95</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">20% from 7-21-96</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div></td></tr></tbody></table></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em><strong>Reference</strong></em>:  For more information on the assignment of a 20-percent evaluation when there is a discharging sinus, see <a href=\"#1a\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.1.a</a> and <a href=\"#1b\" target=\"_self\">b</a>.</span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.D.2.e<a id=\"2e\" name=\"2e\">.</a>  Example of Evaluating Osteomyelitis With a Historical Evaluation Following a Single Recurrence With Scheduled Reduction Due to Inactivity</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  Same facts as example shown in <a href=\"#2d\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.2.d</a>.  A routine future examination was conducted on July 8, 1997, showing the osteomyelitis to be inactive.  There was no discharging sinus, no involucrum, sequestrum, or constitutional symptom.  The most recent episode of active osteomyelitis (July 21, 1996) constitutes the first “recurrent” episode of active osteomyelitis.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Continue the previously assigned 20-percent evaluation, which was awarded on the basis of discharging sinus as a historical evaluation for five years from the examination showing inactivity.  Assign a future ending date for the historical 20-percent evaluation 5 years from the date evidence shows inactivity.</span></span></div><div></div><div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\" summary=\"This is the coded conclusion for this example.\"><thead><tr><th scope=\"col\" style=\"height: 18px; width: 149px; padding: 0px;\"><div align=\"left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em><strong>Coded Conclusion</strong></em>:</span></span></div></th><th scope=\"col\" style=\"height: 18px; width: 354px; padding: 0px;\"></th></tr></thead><tbody><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">1. SC (PTE INC)</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">5000</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Osteomyelitis, right tibia, inactive</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">20% from 7-21-96</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">0% from 7-8-02</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 0px;\"></td></tr></tbody></table></div><div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assigning historical evaluations for osteomyelitis, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1a\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.1.a</a> and <a href=\"#1b\" target=\"_self\">b</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=755d34e320fb96d42a5818c1f95d8812&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5000, Note 2</a>, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">determining whether recurrent episodes of osteomyelitis have occurred, see <a href=\"#1b\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.1.b</a>.</span></span></div></li></ul></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.D.2.f<a id=\"2f\" name=\"2f\">.</a>  Example of Evaluating a Recurrence of Osteomyelitis</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  Same facts as example shown in <a href=\"#2e\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.2.e</a>.  In October 1999, the Veteran was again found to have active osteomyelitis with a discharging sinus, without involucrum, sequestrum, or constitutional symptoms. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Continue the 20-percent evaluation.  Reevaluation is necessary to remove the future reduction to zero percent and to schedule a future examination to establish the date of inactivity.</span></span></div><div></div><div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\" summary=\"This is the coded conclusion for this example.\"><thead><tr><th scope=\"col\" style=\"height: 18px; width: 149px; padding: 0px;\"><div align=\"left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em><strong>Coded Conclusion</strong></em>:</span></span></div></th><th scope=\"col\" style=\"height: 18px; width: 354px; padding: 0px;\"></th></tr></thead><tbody><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">1. SC (PTE INC)</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">5000</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Osteomyelitis, right tibia, active</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">20% from 7-21-96</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 0px;\"></td></tr></tbody></table></div><div></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.D.2.g<a id=\"2g\" name=\"2g\">.</a>  Example of Evaluating Osteomyelitis Following Second Recurrence</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  Same facts as example shown in <a href=\"#2f\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.2.f</a>.  A review examination was conducted on April 8, 2000.  The examination showed the discharging sinus was inactive, and there was no other evidence of active osteomyelitis.  The most recent episode of osteomyelitis (October 1999) constitutes the second \"recurrent\" episode of active osteomyelitis. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  The historical evaluations of 20 and 10 percent both apply.  Continue the 20-percent evaluation based on the historical criteria requiring activity within the past 5 years.  Assign a future ending date for the 20-percent evaluation 5 years from the date of last activity via assigning the lower 10-percent evaluation based on the historical criteria requiring inactive osteomyelitis following repeated episodes without active infection in the past 5 years. </span></span></div><div></div><div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\" summary=\"This is the coded conclusion for this example.\"><thead><tr><th scope=\"col\" style=\"height: 18px; width: 149px; padding: 0px;\"><div align=\"left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em><strong>Coded Conclusion</strong></em>:</span></span></div></th><th scope=\"col\" style=\"height: 18px; width: 354px; padding: 0px;\"></th></tr></thead><tbody><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">1. SC (PTE INC)</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">5000</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Osteomyelitis, right tibia, inactive</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">20% from 7-21-96</span></span></div></td></tr><tr><td style=\"height: 18px; width: 149px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">10% from 4-8-05</span></span></div></td><td style=\"height: 18px; width: 354px; padding: 0px;\"></td></tr></tbody></table></div><div></div><div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assigning historical evaluations for osteomyelitis, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1a\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.1.a</a> and <a href=\"#1b\" target=\"_self\">b</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=755d34e320fb96d42a5818c1f95d8812&amp;mc=true&amp;node=se38.1.4_171a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.71a, DC 5000, Note 2</a>, and</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">determining whether recurrent episodes of osteomyelitis have occurred, see <a href=\"#1b\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.1.b</a>.</span></span></div></li></ul></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.D.2.h<a id=\"2h\" name=\"2h\">.</a>  Example of Evaluating Osteomyelitis Following Curative Resection of Affected Bone</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  Same facts as example shown in <a href=\"#2g\" target=\"_self\">M21-1, Part V, Subpart iii, 1.D.2.g</a>.  The Veteran was hospitalized June 10, 2002, with a recurrent episode of active osteomyelitis.  A radical resection of the right tibia was performed and at hospital discharge (June 21, 2002), the osteomyelitis was shown to be cured.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Assign a temporary total evaluation of 100 percent under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=5f8182af24653683e130814873c6f87b&amp;mc=true&amp;node=se38.1.4_130&amp;rgn=div8\" target=\"_blank\">38 CFR 4.30</a> with a 1-month period of convalescence.  Following application of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=a18de443791ac76fbe390708ba1a3421&amp;mc=true&amp;node=se38.1.3_1105&amp;rgn=div8\" target=\"_blank\">38 CFR 3.105(e)</a>, reduce the evaluation for osteomyelitis to zero percent as an evaluation for osteomyelitis will not be applied following cure by removal or radical resection of the affected bone.</span></span></div><div><div scope=\"col\" style=\"height: 18px; width: 300px\"></div><table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"width: 482px; border-spacing: 0px; border-collapse: revert;\" summary=\"This is the coded conclusion for this example.\"><thead><tr><th scope=\"col\" style=\"height: 18px; width: 203px; padding: 0px;\"><div align=\"left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em><strong>Coded Conclusion</strong></em>:</span></span></div></th></tr></thead><tbody><tr><td style=\"height: 18px; width: 203px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">1. SC (PTE INC)</span></span></div></td></tr><tr><td style=\"height: 18px; width: 203px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">5000</span></span></div></td><td style=\"height: 18px; width: 300px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Osteomyelitis, right tibia, P.O.</span></span></div></td></tr><tr><td style=\"height: 18px; width: 203px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">20% from 7-21-96</span></span></div></td></tr><tr><td style=\"height: 18px; width: 203px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">100% from 6-10-02 (Par. 30)</span></span></div></td></tr><tr><td style=\"height: 18px; width: 203px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">20% from 8-1-02</span></span></div></td></tr><tr><td style=\"height: 18px; width: 203px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">0% from 10-1-02</span></span></div></td><td style=\"height: 18px; width: 300px; padding: 0px;\"></td></tr></tbody></table></div><div></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.D.2.i<a id=\"2i\" name=\"2i\">.</a>  Example of Evaluating Chronic Osteomyelitis</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i>Situation</i></b>:  During active service, a Veteran sustained an injury requiring a bone graft from the pelvis.  A year later, the Veteran was found to have osteomyelitis at the site of the bone graft.  Symptoms were treated with a course of antibiotics.  The Veteran’s symptoms recurred four years later.  Surgical intervention was utilized to treat soft tissue residuals of the osteomyelitis infection.  A chronic sinus tract was found during the surgery.  Two years later, the bone graft site again became infected and was treated with antibiotics, incision, and drainage.  An x-ray confirmed active osteomyelitis at that time.  A follow-up record one year later confirmed no further drainage or symptoms.  Further treatment and follow-up was recommended as physicians suspected that the disease process continued.  However, records thereafter reveal no further treatment. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\">The Veteran submitted a claim for service connection twenty years after the treatment of the last active episode.  No current active infection or symptomatology is shown.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><b><i><span style=\"color: black\">Result</span></i></b><span style=\"color: black\">:  Assign a 100-percent evaluation based on the history of chronic osteomyelitis extending into the pelvis.</span></span></span></div></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><div style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014413\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section C - Arthritis\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014413/M21-1-Part-V-Subpart-iii-Chapter-1-Section-C-Arthritis\">&lt;-- Previous Section</a>  <a articleid=\"554400000014422\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section E - Muscle Injuries\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014422/M21-1-Part-V-Subpart-iii-Chapter-1-Section-E-Muscle-Injuries\">Next Section --&gt;</a></span></span></div><p style=\"text-align: left\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#top\" target=\"_self\"><span style=\"font-size: 11px\">To Top</span></a></span></p></div><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=13bcad22732de2e24d3da7cad62932d5&node=se38.1.4_171a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=20e6c35d263fcb18012ae2dfcf3e5d46&node=se38.1.4_168&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=5f8182af24653683e130814873c6f87b&mc=true&node=se38.1.4_130&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&node=se38.1.4_168&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=a18de443791ac76fbe390708ba1a3421&mc=true&node=se38.1.3_1105&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=b311fb502bb95064c304abc01770f498&node=se38.1.4_171a&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=755d34e320fb96d42a5818c1f95d8812&mc=true&node=se38.1.4_171a&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=92932f5845e33fcc776900678bb1dec3&mc=true&node=se38.1.3_1951&rgn=div8"
  ],
  "scraped_at": "2025-06-16T22:43:34.514556",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014422/M21-1-Part-V-Subpart-iii-Chapter-1-Section-E-Muscle-Injuries"
}